Cellosaurus logo
expasy logo

Cellosaurus ICLU-B (CVCL_E8UA)

[Text version]
Cell line name ICLU-B
Accession CVCL_E8UA
Resource Identification Initiative To cite this cell line use: ICLU-B (RRID:CVCL_E8UA)
Comments Group: Hybridoma fusion partner cell line.
Group: Serum/protein free medium cell line.
Population: African; Nigerian.
Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
Cell type: B-cell; CL=CL_0000236.
Sequence variations
  • Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
  • Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
Disease EBV-related Burkitt lymphoma (NCIt: C27694)
Burkitt lymphoma (ORDO: Orphanet_543)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0511 (Raji)
Children:
CVCL_E8UD (3E7 [Human hybridoma against D.farinae allergen])
Sex of cell Male
Age at sampling 11Y
Category Cancer cell line
Publications

PubMed=10405829; DOI=10.3233/HAB-1999-9202
Hiroharu Kawahara, Mari Maeda-Yamamoto, Makiko Suzuki, Katsuhiro Hakamata;
New human fusion partners, ICLU-B, -T, -E for making human hybridomas derived from various immunological cells.
Hum. Antibodies 9:89-94(1999)

Entry history
Entry creation14-Aug-2025
Last entry update14-Aug-2025
Version number1